(Q34087175)

30 July 2017

Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein (English)

1 reference

30 July 2017

Tassi E

1

1 reference

30 July 2017

Al-Attar A

2

1 reference

30 July 2017

Aigner A

3

1 reference

30 July 2017

Swift MR

4

1 reference

30 July 2017

McDonnell K

5

1 reference

30 July 2017

Karavanov A

6

1 reference

30 July 2017

Wellstein A

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

16 August 2001

1 reference

Journal of Biological Chemistry

30 July 2017

1 reference

30 July 2017

276

1 reference

30 July 2017

40247-40253

1 reference

30 July 2017

43

1 reference

Fibroblast growth factors, their receptors and signaling

30 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

A dual receptor system is required for basic fibroblast growth factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Regulation by heparan sulfate in fibroblast growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

FGF signals for cell proliferation and migration through different pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Growth factors are released by mechanically wounded endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Biological roles of fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

The heparin-binding (fibroblast) growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Fibroblast growth factor-binding protein is a novel partner for perlecan protein core

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Structural characterization of the fibroblast growth factor-binding protein purified from bovine prepartum mammary gland secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Inhibition of fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Up-regulation of a fibroblast growth factor binding protein in children with renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Parallel signal processing among mammalian MAPKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Phosphatidylinositol 3'-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Regulation of gene expression of a binding protein for fibroblast growth factors by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

Molecular and functional aspects of latent transforming growth factor-beta binding protein: just a masking protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104933200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104933200

1 reference

30 July 2017

1 reference